Professional Summary
Professional Overview
Slawomir Wojtowicz-Praga is an experienced Medical Consultant with a diverse background in the pharmaceutical and biotech industries. He specializes in medical affairs, clinical development, and oncology therapeutic areas, leveraging his extensive expertise to provide valuable insights and strategic guidance to his clients.
Experience Summary
Current Role
As a Medical Consultant, Slawomir Wojtowicz-Praga leverages his deep industry knowledge and strong medical background to offer tailored consulting services to his clients. In this role, he provides strategic counsel, clinical trial oversight, and medical affairs support, helping organizations navigate complex regulatory landscapes and drive successful drug development initiatives.
Career Progression
Slawomir Wojtowicz-Praga's career spans over two decades in the pharmaceutical and biotech industries. Prior to his current role, he held various leadership positions, including Vice President and Head of Medical Affairs at Premier Research, Senior Medical Director at Mirati Therapeutics and Quintiles, and Group Director of Bio-Oncology Medical Affairs at Genentech. Throughout his career, he has demonstrated a strong track record of driving strategic initiatives, leading cross-functional teams, and contributing to the development and commercialization of innovative therapies.
Academic Background
Slawomir Wojtowicz-Praga holds an MD from the Medical University of Gdańsk and additional training in Medical Oncology and Developmental Therapeutics from Georgetown University School of Medicine. He also completed his Internal Medicine residency at Henry Ford Hospital in Detroit, MI.
Areas of Expertise
- Medical affairs strategy and implementation
- Clinical trial design and oversight
- Oncology and developmental therapeutics
- Regulatory compliance and liaison
- Cross-functional team leadership
- Stakeholder engagement and collaboration
Professional Impact
Throughout his career, Slawomir Wojtowicz-Praga has made significant contributions to the pharmaceutical and biotech industries. He has been instrumental in the successful development and commercialization of several oncology and specialty products, leveraging his deep medical expertise and strategic acumen to drive positive outcomes for his clients and the patients they serve.
Conclusion
With his extensive experience, strong medical background, and proven track record of success, Slawomir Wojtowicz-Praga is a valuable asset to organizations seeking expert medical consultation and strategic guidance in the pharmaceutical and biotech industries. His commitment to excellence and passion for advancing patient care make him a highly sought-after professional in his field.
